Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_assertion type Assertion NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_head.
- NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_assertion description "[Because the majority of colon carcinomas are known to overexpress antiapoptotic proteins such as survivin and Bcl-2 and show only limited ability to undergo apoptosis, we hypothesized that the ability of sulindac to cause regression of adenomas and to inhibit colon carcinogenesis is mediated, at least in part, by down-regulation of one or more of these antiapoptotic proteins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_provenance.
- NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_assertion evidence source_evidence_literature NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_provenance.
- NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_assertion SIO_000772 14610217 NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_provenance.
- NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_assertion wasDerivedFrom befree-2016 NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_provenance.
- NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_assertion wasGeneratedBy ECO_0000203 NP420073.RAyahEJQuILbuD6mJMp9QzTkjTD4jfYaTUxfMReyxLlWE130_provenance.